Shao et al. (2022) reported that LOXL1 is one of the key osteoclast differentiation-related genes (ODRGs). LOXL1 is predominantly highly expressed in metastatic tumor cells and serves as a significant predictor of patient survival (Shao et al., 2022). This evidence concerns the gene LOXL1 and neoplasm.